SCHEMBL2490350

SCHEMBL2490350

[CH2]c1ccccc1-c1ccccc1O

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.50
HPGD P15428 2/20 0.50
HSD17B10 Q99714 2/20 0.50
BCL2L1 Q07817 1/20 0.50
SMN1; SMN2 Q16637 2/20 0.45
L3MBTL1 Q9Y468 2/20 0.45
ALOX15 P16050 2/20 0.45
MAPT P10636 2/20 0.45
KDM4E B2RXH2 1/20 0.45
NPC1 O15118 1/20 0.45
CA12 O43570 1/20 0.45
GMNN O75496 1/20 0.45
EGFR P00533 1/20 0.45
CA2 P00918 1/20 0.45
LMNA P02545 1/20 0.45
FYN P06241 1/20 0.45
POLB P06746 1/20 0.45
CA3 P07451 1/20 0.45
CYP3A4 P08684 1/20 0.45
MMP9 P14780 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ethylene SCHEMBL7112141 0.83 ALDH1A1 (0.60) ALDH1A1HPGDHSD17B10BCL2L1SMN1; SMN2
SCHEMBL30442890 0.83 ALDH1A1 (0.67) ALDH1A1HPGDHSD17B10BCL2L1SMN1; SMN2
SCHEMBL17503644 0.83 MEN1 (0.39) ALDH1A1HPGDHSD17B10BCL2L1SMN1; SMN2
SCHEMBL28574 0.83 ALDH1A1 (0.67) ALDH1A1HPGDHSD17B10BCL2L1SMN1; SMN2
SCHEMBL29623192 0.83 ALDH1A1 (0.67) ALDH1A1HPGDHSD17B10BCL2L1SMN1; SMN2
SCHEMBL2492794 0.81 ALDH1A1 (0.43) ALDH1A1HPGDHSD17B10BCL2L1SMN1; SMN2
SCHEMBL7845497 0.80 ALDH1A1 (0.63) ALDH1A1HPGDHSD17B10BCL2L1SMN1; SMN2
SCHEMBL986607 0.80 ALDH1A1 (0.63) ALDH1A1HPGDHSD17B10BCL2L1SMN1; SMN2
Hydrogen Sulfide SCHEMBL20536042 0.80 ALDH1A1 (0.63) ALDH1A1HPGDHSD17B10BCL2L1SMN1; SMN2
Catechol SCHEMBL21408977 0.80 ALDH1A1 (0.71) ALDH1A1HPGDHSD17B10BCL2L1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2380567-B1 MELANIN PRODUCTION INHIBITOR POLA CHEM IND INC (JP) 2019-01-16 EP disclosed
EP-3009123-A1 MELANIN PRODUCTION INHIBITOR Pola Chemical Industries Inc. (JP) 2016-04-20 EP disclosed
US-20150328107-A1 MELANIN PRODUCTION INHIBITOR POLA CHEMICAL INDUSTRIES INC. (JP) 2015-11-19 US disclosed
EP-2845587-A2 Melanin production inhibitor Pola Chemical Industries Inc. (JP) 2015-03-11 EP disclosed
US-20140363389-A1 MELANIN PRODUCTION INHIBITOR POLA CHEMICAL INDUSTRIES INC. (JP) 2014-12-11 US disclosed
US-8846012-B2 Melanin production inhibitor POLA CHEMICAL INDUSTRIES INC. (JP) 2014-09-30 US disclosed
EP-2380567-A1 MELANIN PRODUCTION INHIBITOR Pola Chemical Industries Inc. (JP) 2011-10-26 EP disclosed
US-20110243865-A1 MELANIN PRODUCTION INHIBITOR POLA CHEMICAL INDUSTRIES INC. (JP) 2011-10-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110243865-A1 MELANIN PRODUCTION INHIBITOR TYR, F12, TH ALDH1A1 1292/4885HPGD 1749/4885HSD17B10 805/4885
US-20150328107-A1 MELANIN PRODUCTION INHIBITOR TYR, MC1R, F12 ALDH1A1 1031/4885HPGD 1563/4885HSD17B10 719/4885
US-20140363389-A1 MELANIN PRODUCTION INHIBITOR TYR, F12, MC1R ALDH1A1 1187/4885HPGD 1618/4885HSD17B10 797/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.